But dig deeper, and you see that most of this revenue is from medical cannabis, which accounted for 81% of total revenue. Meanwhile, the consumer cannabis business is collapsing, with revenue down 48% YOY, as the company deliberately exits lower-margin areas. Profitability looked better in the quarter for a company that has long struggled to achieve it. Adjusted EBITDA totaled $18.5 million, with net income of $7.2 million. Also, the company generated free cash flow of $15.5 million.Over the past five years ...